Interaction between pazufloxacin and DNA mediated by copper(II) ions

Journal of Fluorescence

Volumn 18, Issue 3-4, 2008, Pages 701-706

  Zhang, Guoliang ^a,b   Fu, Xuchun ^c   Liu, Qingwang ^b   Wang, Guoping ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b Downhole Service Sub company of Daqing Oilfields Co   (China)

^c ZHEJIANG UNIVERSITY CITY COLLEGE   (China)

Author keywords

Calf thymus DNA; Copper(II) ion; Fluorescence; Pazufloxacin

Indexed keywords

ANTIMICROBIAL AGENTS; CALF THYMUS DNA (CT DNA); COPPER(II) IONS; PAZUFLOXACIN; QUINOLONE;

ABSORPTION; CHARGED PARTICLES; COPPER; DNA; ELECTROLYSIS; ELECTRONS; GENES; HEALTH; NUCLEIC ACIDS; ORGANIC ACIDS; VISCOSITY MEASUREMENT;

ABSORPTION SPECTROSCOPY;

CALF THYMUS DNA; COPPER; DNA; OXAZINE DERIVATIVE; PAZUFLOXACIN; QUINOLONE DERIVATIVE; TUBERCULOSTATIC AGENT;

CHEMISTRY; CONFERENCE PAPER; SPECTROFLUOROMETRY; SPECTROPHOTOMETRY; ULTRAVIOLET SPECTROPHOTOMETRY; VISCOSITY;

ANTITUBERCULAR AGENTS; COPPER; DNA; FLUOROQUINOLONES; OXAZINES; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY; SPECTROPHOTOMETRY, ULTRAVIOLET; VISCOSITY;

INSECTIVORA;

EID: 46149090833     PISSN: 10530509     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10895-008-0342-1     Document Type: Conference Paper

References (19)

1. Hooper DC, Wolfson JS (1993) Quinolone antimicrobial agents, 2nd edn. American Society of Microbiology, Washington DC
2. Nomura N, Mitsuyama J, Furuta Y, Yamada H, Nakata M, Fukuda T, Takahata M, Minami S (2002) In vitro and in vivo antibacterial activities of pazufloxacin mesilate, a new injectable quinolone. Jpn J Antibiot 55:412
3. Turel I (2002) The interactions of metal ions with quinolone antibacterial agents. Coord Chem Rev 232(1-2):27
4. Wu GG, Wang GP, Fu XC, Zhu LG, Yu QS (2003) Synthesis, crystal structure, stacking effect and antibacterial studies of a novel quaternary copper (II) complex with quinolone. Molecules 8(2):287
5. Wang GP, Zhu LG (2002) Synthesis and crystal structure of a new copper(II) complex containing fluoroquinolone. Frontiers of solid state chemistry. World Scientific, Singapore
6. 2+. J Fluoresc 14:705
7. Reece RJ, Maxwell A (1991) DNA gyrase: structure, mechanism, and interaction with antibiotics. CRC Crit Rev Biochem 26:335
8. Wigley DB (1995) Structure and mechanism of DNA gyrase. In: Eckstein F, Lilley DMJ (eds) Nucleic acids and molecular biology. vol. 9. Springer, Berlin, p 165
9. Son GS, Yeo J-A, Kim M-S, Kim SK, Holmen A, Akerman B, Norden B (1998) Binding mode of norfloxacin to calf thymus DNA. J Am Chem Soc 120:6451
10. Bailly C, Colson P, Houssier C (1998) The orientation of norfloxacin bound to double-stranded DNA. Biochem Biophys Res Commun 243:844
11. Shen LL, Pemet AG (1985) Mechanism of inhibition of DNA gyrase by analogues nalidixic acid: the target of the drugs is DNA. Proc Natl Acad Sci U S A 82:307
12. Shen LL, Mitscher LA, Sharma PN, O, 'Donnel TJ, Chu DW, Cooper CS, Rosen T, Pemet AG (1989) Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug-DNA binding model. Biochemistry 28:3886
13. Palu G, Valisena G, Ciarrocchi G, Gatto B, Palumbo M (1992) Quinolone binding to DNA is mediated by magnesium ions. Proc Natl Acad Sci U S A 89:9671
14. Drevensek P, Turel I, Ulrih NP (2003) Influence of copper (II) and magnesium (II) ions on the ciprofloxacin binding to DNA. J Inorg Biochem 96:407
15. Guo DS, Yuan XY, Wu JB (2007) Influence of Cr(III) and Cr(VI) on the interaction between sparfloxacin and calf thymus DNA. J Inorg Biochem 101:644
16. Nagababu P, Latha JNL, Satyanarsyana S (2006) DNA-binding studies of mixed-ligand (ethylenediamine)ruthenium(ii) complexes. Chemistry & Biodiversity 3(11):1219
17. Al-Mustafa J, Tashtoush B (2003) Iron (II) and iron (III) perchlorate complexes of ciprofloxacin and norfloxacin. J Coord Chem 56(2):113
18. Long EC, Barton JK (1990) On demonstrating DNA intercalation. Acc Chem Res 23:271
19. Satyanarsyana S, Dabrowiak JC, Chaires JB (1992) Neither D- nor l-tris(phenanthroline) ruthenium(II) binds to DNA by classical intercalation. Biochemistry 31(39):9319